February 2023 - Page 6 of 8

FridayFeb 10, 2023 10:30 am

Purposeful Earth Stewardship Drives Innovation for Luxury B&B Brand Developer Coyuchi Inc.

Coyuchi Inc. is a California-based bed and bath lifestyle brand focused on sustainable practices and producing comfortable, organic products The company had a net income of $1.4 million on sales of $33 million last year Coyuchi is expanding its product line with two new items sourced from cotton that the company helped grow as part of a collaborative, soil-rejuvenating project last year The company launched a Reg A+ investment offering last year and announced that capital raised had topped $1 million by the end of the year In a recent podcast interview, the company’s CEO and president outlined Coyuchi’s priorities…

FridayFeb 10, 2023 9:45 am

Sharing Services Global Corp. (SHRG) Dedicated to Developing Opportunities in Growing Direct-Selling Space

A new report projects that the global direct-selling establishments market size will grow from $688.45 billion in 2022 to $763.85 billion in 2023 SHRG is focused on positioning itself to take advantage of projected growth The company has developed opportunities in several spaces, including the health and wellness, travel, and restaurant sectors In a market forecast to see almost $80 billion growth (https://nnw.fm/cZo3Z), Sharing Services Global (OTCQB: SHRG) is working to offer a variety of options for its brand partners, subscribers and independent sales force. SHRG operates in the direct-selling space, where it is dedicated to developing or acquiring businesses,…

FridayFeb 10, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expecting Additional Growth in 2023, Including IND Filing and IND Clinical Study

In addition to a recently released shareholder update letter from the company’s CEO, Chris Bunka, Lexaria Bioscience has now released a new investor presentation Despite 2022 inflationary conditions, Lexaria has seen growth company-wide – including hitting annual budgets +/- 2% over the last two years Lexaria’s patented DehydraTECH(TM) technology offers more effective delivery of active pharmaceutical ingredients into the bloodstream and brain tissue with 28 patents granted and roughly 50 patent applications pending worldwide For Q1 2023, Lexaria expects additional results from its hypertension study HYPER-H21-4, dosing completion in its animal dementia study and diabetes study, dosing completion in human…

ThursdayFeb 09, 2023 10:30 am

Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference

Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT(R) to the U.S. FDA. proBEAT(TM) combines non-invasive glucose data processed using artificial intelligence and a digital healthcare…

ThursdayFeb 09, 2023 9:45 am

Utopia VR Pioneers ‘Metaverse-As-A-Service’, Seeks to Revolutionize the Workplace as We Know It

The modern workplace has undergone a radical shift in recent years, moving increasingly away from an office-centric model towards a more hybrid working environment Corporate employees are revealing they are increasingly spending more time in meetings, with over 77% of these taking place online Users can host and attend meetings in lifelike virtual reality – with no software downloads – engaging their audiences in a more collaborative and fun way In April 2022, the company launched the world’s first web-based, mobile-friendly, audio and video conference platform Early on Tuesday 8th January 2019, WeWork announced that the company had successfully concluded…

ThursdayFeb 09, 2023 9:00 am

REZYFi, Inc. Provides the Cannabis Industry with Critical Financing Options and Services Still Not Available with Traditional Banking Institutions

Cannabis businesses continue to face challenges finding opportunities for financing despite the continued drive for legalization REZYFi is pivotal providing much-needed support to the cannabis industry through two wholly owned subsidiaries – REZYFi Lending and ResMac Inc. For 2023, combined cannabis industry sales are projected to reach $38.8 billion In recent years, the cannabis industry has seen significant changes – with 39 states legalizing cannabis for medicinal use and 21 states allowing recreational use. For 2023, the combined sales are projected to reach $38.8 billion for the industry (https://nnw.fm/MFszj). In spite of this significant growth, there is a challenge that…

WednesdayFeb 08, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Commissions Demonstration Plant; Plans for Louisiana Strategic Metals Complex

Ucore’s RapidSX(TM) Demonstration Plant will be located within the company’s 5000 square foot Commercialization and Demonstration Facility in Kingston, Ontario A Strategic Metals Complex is being planned in Louisiana with an initial capacity of 2,000 tonnes per annum and increasing to production of 5,000 tonnes Cerium, neodymium, lanthanum, praseodymium, yttrium, and dysprosium are expected to remain the most sought-after REEs, with high demands in magnet manufacturing and the automobile industry The global rare earth element market was valued at $2.8 billion in 2018 and is expected to grow at a CAGR of 10.4% through 2025 Ucore Rare Metals (TSX.V: UCU)…

WednesdayFeb 08, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Encouraged by Nanosized Antibody Study Results as Market Forecasts Predict Rapid Growth

Market analysts predict monoclonal antibodies (“mAbs”) will be the fastest-growing revenue segment of the biologics medicinal market through the end of the decade BiondVax Pharmaceuticals is focused on developing and commercializing novel mAb “biobetter” NanoAbs to meet underserved medical needs addressing large market disorders The company’s recent work with an inhaled nanosized antibody for COVID has shown exceptionally promising results, virtually preventing illness and eliminating the SARS-COV-2 virus in a hamster population With COVID as first target, the company’s pipeline aims to provide effective medical responses to other disorders such asthma, psoriasis, psoriatic arthritis, and macular degeneration Immunotherapeutic product innovator…

WednesdayFeb 08, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) – Technology Behind Patented Disruptive DehydraTECH(TM) Drug Delivery Platform

Lexaria has developed the DehydraTECH drug delivery technology, which enhances the performance of multiple categories of fat-soluble active molecules and drugs DehydraTECH has been shown to increase intestinal bioabsorption of certain bioactive compounds by as much as 27 times, with its onset of action being as little as 1.5 minutes The technology is also expected to lower the overall drug costs because it delivers more active molecules to the blood plasma and brain, thus necessitating lower dosing, all while resulting in cost-effective manufacturing DehydraTECH is protected by 28 patents granted worldwide, with approximately 50 more pending Speaking during a late…

TuesdayFeb 07, 2023 10:30 am

REZYFi, Inc. Anticipates Increased Demand for its Services Following Rise in Mortgage Demand

30-year fixed-rate mortgages with conforming loan balances of $726,200 or less, saw rates decrease from 6.42% to 6.23% for the week ending January 18, 2023, resulting in a 28% increase in mortgage application volume, and a 34% increase in refinance demand It is projected that by the end of 2023, mortgage rates in the country will drop by 5.25%, coming from 2022, which saw home financing costs nearly double These rate drops present an opportunity for REZYFi to grow its customer reach, market share, and revenue but also offer an avenue for the growth of the housing finance sector REZYFi,…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: February 2023